Multiple Myeloma Coverage from Every Angle

Muzaffar H. Qazilbash, MD, on Multiple Myeloma: Results From a Treatment Trial

Posted: Monday, December 11, 2017

Muzaffar H. Qazilbash, MD, of The University of Texas MD Anderson Cancer Center, discusses phase III study findings on busulfan plus melphalan vs melphalan alone for patients with multiple myeloma.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.